دورية أكاديمية
An introduction to therapeutic approaches to vascular cognitive impairment
| العنوان: | An introduction to therapeutic approaches to vascular cognitive impairment |
|---|---|
| المؤلفون: | Atticus H Hainsworth, Fanny M Elahi, Roderick A Corriveau |
| المصدر: | Cerebral Circulation - Cognition and Behavior, Vol 2, Iss , Pp 100033- (2021) |
| بيانات النشر: | Elsevier, 2021. |
| سنة النشر: | 2021 |
| المجموعة: | LCC:Specialties of internal medicine LCC:Neurosciences. Biological psychiatry. Neuropsychiatry |
| مصطلحات موضوعية: | Vascular cognitive impairment, VCID, Vascular dementia, Treatments, Clinical trials, Drugs, Specialties of internal medicine, RC581-951, Neurosciences. Biological psychiatry. Neuropsychiatry, RC321-571 |
| الوصف: | Vascular cognitive impairment (VCI), encompassing vascular dementia, has been claimed as the “second-most common dementia” after Alzheimer Disease. Whether or not this is true, the clinical picture of most dementia in older people includes vascular disease. There are no validated pharmacological targets for prevention or treatment of VCI. This has inspired a multitude of potential treatment approaches, reflected by the articles in this Special Issue. These include in vitro testing of the novel oral anticoagulant dabigatran for protection against β-amyloid neurotoxicity, and an overview of neuroinflammation in VCI and the role of circulating markers (PIGF, VEGF-D) identified by the MarkVCID study. There are reviews of potential therapeutics, including adrenomedullin and nootropic preparations (exemplified by cerebrolysin). The role of sleep is reviewed, with possible therapeutic targets (5HT2A receptors). There is a clinical study protocol (INVESTIGATE-SVD) and a feasibility analysis for a secondary prevention trial in small vessel disease. Clinical data include secondary analyses of blood pressure and cerebral blood flow from a longitudinal clinical trial (NILVAD), differences between methylphenidate and galantamine responders and non-responders (STREAM-VCI), appraisal of treatment approaches in India, and primary outcomes from a randomised trial of Argentine tango dancing to preserve cognition in African American women (ACT). Treating vascular disease has great potential to improve global cognitive health, with public health impacts alongside individual benefit. Vascular disease burden varies across populations, offering the possibility of proactively addressing health inequity in dementia using vascular interventions. The next 5–10 years will witness cost-effective lifestyle interventions, repurposed drugs and novel therapeutics. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 2666-2450 |
| Relation: | http://www.sciencedirect.com/science/article/pii/S2666245021000301; https://doaj.org/toc/2666-2450 |
| DOI: | 10.1016/j.cccb.2021.100033 |
| URL الوصول: | https://doaj.org/article/aef45284f30b42fd8664af5da18d87f1 |
| رقم الأكسشن: | edsdoj.f45284f30b42fd8664af5da18d87f1 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 26662450 |
|---|---|
| DOI: | 10.1016/j.cccb.2021.100033 |